Compugen Ltd (CGEN)

Jul 27, 2026

Compugen Ltd (CGEN) Income Statement - TradingKey

Jul 27, 2026

Jul 27, 2026

CGEN|Compugen Ltd|Price:2.365|Chg%:+0.085 - TradingKey

Jul 27, 2026

Jul 27, 2026

Compugen Ltd (CGEN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026

Jul 27, 2026

Compugen Ltd (CGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 27, 2026

Jul 27, 2026

CGEN|Compugen Ltd|Price:2.375|Chg%:+0.095 - TradingKey

Jul 27, 2026

Jul 26, 2026

Compugen Ltd (CGEN) Cash Flow - TradingKey

Jul 26, 2026

Jul 25, 2026

TradingKey - TradingKey

Jul 25, 2026

Jul 25, 2026

CGEN|Compugen Ltd|Price:2.280|Chg%:-0.060 - TradingKey

Jul 25, 2026

Jul 23, 2026

Evogene Ltd. (EVGN) stock price, news, quote and history - Yahoo Finance UK

Jul 23, 2026

Jul 22, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Jul 22, 2026

Jul 21, 2026

Lake Street Maintains Compugen(CGEN.US) With Buy Rating, Raises Target Price to $6 - Moomoo

Jul 21, 2026

Jul 21, 2026

Compugen to Participate in BTIG Biotechnology Conference 2026 - marketscreener.com

Jul 21, 2026

Jul 20, 2026

Compugen (CGEN) to Release Q2 Financial Results on August 3, 202 - GuruFocus

Jul 20, 2026

Jul 20, 2026

Compugen's Cancer Immunotherapy Update Is Set for Aug. 3 - Stock Titan

Jul 20, 2026

Jul 20, 2026

Compugen to release Q2 2026 results, host conference call - Bitget

Jul 20, 2026

Jul 13, 2026

Compugen (CGEN) SVP Levine exercises options and sells 1,875 shares under plan - Stock Titan

Jul 13, 2026

Jul 10, 2026

CGEN Stock Update: Virtual Meeting Announcement - GuruFocus

Jul 10, 2026

Jul 06, 2026

Compugen Ltd. (CGEN) Surges 3.5% Amid Biotech Sector Renewed InterestBollinger Expansion - dars.gov.et

Jul 06, 2026

Jul 02, 2026

Compugen Q1 2026 Earnings: EPS Misses Estimates, No Revenue ReportedEarnings Power Value - dars.gov.et

Jul 02, 2026

Jun 30, 2026

Compugen (CGEN) Edges Lower as Shares Test Support Near $2.03Gamma Squeeze - dars.gov.et

Jun 30, 2026

Jun 29, 2026

CGEN Q1 2026 Earnings: Narrowing Net Loss and Pipeline Progress Fuel OptimismGuidance Revision Trend - dars.gov.et

Jun 29, 2026

Jun 27, 2026

Compugen Ltd (CGEN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus

Jun 27, 2026

Jun 27, 2026

Compugen Ltd (CGEN) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 27, 2026

Jun 26, 2026

Enterprise value to EBITDA forward of Compugen Ltd. – NASDAQ:CGEN - TradingView

Jun 26, 2026

Jun 26, 2026

Enterprise value to revenue forward of Compugen Ltd. – NASDAQ:CGEN - TradingView

Jun 26, 2026

Jun 26, 2026

Enterprise value to EBIT forward of Compugen Ltd. – NASDAQ:CGEN - TradingView

Jun 26, 2026

Jun 26, 2026

Price to sales forward of Compugen Ltd. – NASDAQ:CGEN - TradingView

Jun 26, 2026

Jun 26, 2026

Compugen Ltd. Actuals & Estimates (NASDAQ:CGEN) - TradingView

Jun 26, 2026

Jun 26, 2026

Compugen Ltd (CGEN) Institutional Confidence - TradingKey

Jun 26, 2026

Jun 26, 2026

Compugen Ltd. Actuals & Estimates (TASE:CGEN) - TradingView

Jun 26, 2026

Jun 25, 2026

CGEN Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 24, 2026

Lake Street Maintains Compugen(CGEN.US) With Buy Rating, Cuts Target Price to $5 - Moomoo

Jun 24, 2026

Jun 18, 2026

Compugen presents ovarian cancer trial poster at ESMO meeting - Investing.com UK

Jun 18, 2026

Jun 18, 2026

Compugen presents ovarian cancer trial poster at ESMO meeting By Investing.com - Investing.com South Africa

Jun 18, 2026

Jun 18, 2026

Compugen spotlights COM701 ovarian trial at ESMO congress - Stock Titan

Jun 18, 2026

Jun 18, 2026

Compugen presents trial data on COM701 for ovar... - Pluang

Jun 18, 2026

Jun 18, 2026

Compugen (CGEN) Stock Faces Mixed Analyst Target Changes After Cautious Valuation Revisions - Yahoo Finance UK

Jun 18, 2026

Jun 17, 2026

Compugen Ltd (CGEN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Compugen Ltd (CGEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 17, 2026

Jun 17, 2026

Compugen Ltd (CGEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026

Jun 17, 2026

Compugen Ltd (CGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026

Jun 17, 2026

Compugen Ltd (CGEN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026

Jun 16, 2026

CGEN Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Stage Continues; Stock DeclinesStrong Earnings Momentum - newsline.com

Jun 16, 2026

Jun 14, 2026

CGEN Q1 2026 Earnings: EPS Misses Estimates amid R&D FocusRevenue Beat Analysis - newsline.com

Jun 14, 2026

Jun 14, 2026

Compugen Ltd. (CGEN) Q1 2026 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Continues DevelopmentBuyback Announcement Report - dars.gov.et

Jun 14, 2026

Jun 11, 2026

Compugen Ltd (CGEN) to Present MAIA-Ovarian Trial Progress at Eu - GuruFocus

Jun 11, 2026

Jun 11, 2026

COMPUGEN ($CGEN) Releases Q4 2025 Earnings - Quiver Quantitative

Jun 11, 2026

Jun 11, 2026

Compugen to present ovarian cancer trial poster at ESMO - Investing.com UK

Jun 11, 2026

Jun 11, 2026

Compugen to present ovarian cancer trial poster at ESMO By Investing.com - Investing.com South Africa

Jun 11, 2026

Jun 11, 2026

AI-driven cancer firm to present ovarian trial at ESMO 2026 - Stock Titan

Jun 11, 2026

Jun 11, 2026

Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026 - Yahoo Finance

Jun 11, 2026